ELENA DELBUSTO: Open Payments
NPI 1154541712 · HAVERFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 40 payments from 17 companies in 2025. Trend: 2023 $1,343 · 2024 $1,060 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $148 |
| ABBVIE INC. | 6 | $102 |
| Collegium Pharmaceutical, Inc. | 5 | $92 |
| Eisai Inc. | 3 | $83 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
Products named: XYWAV, VRAYLAR, Jornay PM, Leqembi, Auvelity, INGREZZA, FANAPT, CAPLYTA.
Industry payments across PA — which companies pay providers there.
